Ductal carcinoma in situ--current management.

[1]  Robert D Cardiff,et al.  Ductal carcinoma in situ: state of the science and roadmap to advance the field. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Daniel F Chen,et al.  Magnetic resonance imaging captures the biology of ductal carcinoma in situ. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  M. Antoine,et al.  Ductal carcinoma in situ: Value of sentinel lymph node biopsy , 2006, Journal of surgical oncology.

[4]  N. Kapucuoglu,et al.  CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. , 2006, Pathology, research and practice.

[5]  Peter Bult,et al.  The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. , 2006, American journal of surgery.

[6]  J. Peterse,et al.  Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Chiara Zuiani,et al.  Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial. , 2006, AJR. American journal of roentgenology.

[8]  Kay Nieselt,et al.  Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. , 2006, Cancer research.

[9]  S. Jaffer,et al.  Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Sheryl G. A. Gabram,et al.  Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial , 2006, Annals of Surgical Oncology.

[11]  Barbara L. Smith,et al.  Prospective study of wide excision alone for ductal carcinoma in situ of the breast. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. Morrow,et al.  Effect of reexcision on the success of breast-conserving surgery , 1995, Annals of Surgical Oncology.

[13]  S. Piato,et al.  Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium , 2006, Breast Cancer Research and Treatment.

[14]  G. Vogl,et al.  Angiogenic potential of ductal carcinoma in situ (DCIS) of human breast , 2005, Histopathology.

[15]  F. Vicini,et al.  Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. , 2005, International journal of radiation oncology, biology, physics.

[16]  J. Cendan,et al.  Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ: An Evolving Approach at the University of Florida , 2005, The breast journal.

[17]  E. Winer,et al.  American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Sharon Nofech-Mozes,et al.  Prognostic and Predictive Molecular Markers in DCIS: A Review , 2005, Advances in anatomic pathology.

[19]  Angela Fagerlin,et al.  Patient involvement in surgery treatment decisions for breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  U. Jeschke,et al.  Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone. , 2005, Anticancer research.

[21]  A. Fagerlin,et al.  Patterns and correlates of local therapy for women with ductal carcinoma-in-situ. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  H. Bartelink,et al.  Long‐term outcome after breast‐conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast , 2005, Cancer.

[23]  E. Mittendorf,et al.  Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. , 2005, Current surgery.

[24]  M Baum,et al.  Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer , 2005, The Lancet.

[25]  L. Hefler,et al.  Transforming growth factor beta 1 serum levels in patients with preinvasive and invasive lesions of the breast. , 2004, The International journal of biological markers.

[26]  R. Golub,et al.  Cost minimization study of image-guided core biopsy versus surgical excisional biopsy for women with abnormal mammograms. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  Kornelia Polyak,et al.  Ductal Carcinoma in Situ of the Breast , 2004, Strahlentherapie und Onkologie.

[28]  R. Zeillinger,et al.  CXCR4 is Expressed in Ductal Carcinoma in situ of the Breast and in Atypical Ductal Hyperplasia , 2004, Breast Cancer Research and Treatment.

[29]  R. Schulz-Wendtland,et al.  Stereotactic vacuum‐assisted breast biopsy in 2874 patients , 2004, Cancer.

[30]  D. May,et al.  Mammography and breast cancer detection by race and Hispanic ethnicity: results from a national program (United States) , 2000, Cancer Causes & Control.

[31]  I. Christensen,et al.  Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy , 2000, Breast Cancer Research and Treatment.

[32]  L. Murphy,et al.  S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast , 2004, Breast Cancer Research.

[33]  J. Lara,et al.  The relevance of occult axillary micrometastasis in ductal carcinoma in situ , 2003, Cancer.

[34]  J. Houghton.  Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial , 2003, The Lancet.

[35]  L. Belghiti,et al.  Prognostic factors in breast cancer , 2002 .

[36]  A. Douglas-Jones,et al.  Diagnostic difficulty arising from displaced epithelium after core biopsy in intracystic papillary lesions of the breast , 2002, Journal of clinical pathology.

[37]  C. Lemanski,et al.  Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience. , 2002, International journal of radiation oncology, biology, physics.

[38]  A. Giuliano,et al.  Proceedings of the Consensus Conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania , 2002, Cancer.

[39]  B. Cady,et al.  The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast , 2002, Cancer.

[40]  D. Dillon,et al.  Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy. , 2001, International journal of radiation oncology, biology, physics.

[41]  D. Carter,et al.  Breast carcinoma in situ: risk factors and screening patterns. , 2001, Journal of the National Cancer Institute.

[42]  P. Lantz,et al.  Correlates of surgical treatment type for women with noninvasive and invasive breast cancer. , 2001, Journal of women's health & gender-based medicine.

[43]  N. Wolmark,et al.  Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. , 2001, Seminars in oncology.

[44]  T. Lennard,et al.  Aggressive local treatment for screen-detected DCIS results in very low rates of recurrence. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[45]  D. Schultz,et al.  Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. , 2001, International journal of radiation oncology, biology, physics.

[46]  D. Naimark,et al.  A comparison of four treatment strategies for ductal carcinoma in situ using decision analysis , 2001, Cancer.

[47]  D. Reintgen,et al.  Importance of Lymphatic Mapping in Ductal Carcinoma in Situ (DCIS): Why Map DCIS? , 2001, The American surgeon.

[48]  R. Brem,et al.  Reliability of Histologic Diagnosis of Breast Cancer with Stereotactic Vacuum-Assisted Biopsy , 2001, The American surgeon.

[49]  M. Morrow,et al.  Prospective Comparison of Stereotactic Core Biopsy and Surgical Excision as Diagnostic Procedures for Breast Cancer Patients , 2001, Annals of surgery.

[50]  D. Schultz,et al.  Salvage treatment for local recurrence after breast‐conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast , 2001, Cancer.

[51]  W. P. Evans,et al.  Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. , 2001, Radiology.

[52]  C. Lee,et al.  Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? , 2000, Radiology.

[53]  A. Miller,et al.  Organized breast cancer screening programs in Canada. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[54]  I. Olivotto,et al.  Ten years of breast screening in the Screening Mammography Program of British Columbia, 1988–97 , 2000, Journal of medical screening.

[55]  S. Edge,et al.  Prognostic factors in breast cancer , 2005 .

[56]  D. Page,et al.  Benign transport of breast epithelium into axillary lymph nodes after biopsy. , 2000, American journal of clinical pathology.

[57]  L. Liberman,et al.  Sentinel Lymph Node Biopsy: Is It Indicated in Patients With High-Risk Ductal Carcinoma-In-Situ and Ductal Carcinoma-In-Situ With Microinvasion? , 2000, Annals of Surgical Oncology.

[58]  G. Hortobagyi,et al.  Ductal Carcinoma-In-Situ: Long-Term Results of Breast-Conserving Therapy , 2000, Annals of Surgical Oncology.

[59]  B. Gusterson,et al.  Role of immunohistochemical detection of lymph-node metastases in management of breast cancer , 1999, The Lancet.

[60]  J Costantino,et al.  Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of Protocol B‐17 , 1999, Cancer.

[61]  V. Jackson,et al.  Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11-gauge vacuum-assisted device: persistent underestimation of disease. , 1999, AJR. American journal of roentgenology.

[62]  James Dignam,et al.  Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial , 1999, The Lancet.

[63]  T. Sellers,et al.  Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. , 1999, JAMA.

[64]  S. Moss.  16-year mortality from breast cancer in the UK Trial of Earaly Detection of Breast Cancer , 1999, The Lancet.

[65]  S. Martino,et al.  The influence of margin width on local control of ductal carcinoma in situ of the breast. , 1999, The New England journal of medicine.

[66]  A. Gad,et al.  Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology. , 1998, Human pathology.

[67]  L. Liberman,et al.  Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy. , 1998, Radiology.

[68]  K. Hughes,et al.  Ductal Carcinoma In Situ: The Impact of Screening on Clinical Presentation and Pathologic Features , 1998 .

[69]  S. Martino,et al.  Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  D. May,et al.  The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women. , 1998, AJR. American journal of roentgenology.

[71]  M. Amichetti,et al.  Ten-year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy. , 1997, European journal of cancer.

[72]  M. Silverstein,et al.  Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies. , 1997, Surgical oncology clinics of North America.

[73]  C. Quinn,et al.  Ductal carcinoma in situ of the breast: the clinical significance of histological classification , 1997, Histopathology.

[74]  E A Sickles,et al.  Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. , 1997, Journal of the National Cancer Institute.

[75]  F. Gilliland,et al.  The New Mexico Mammography Project: Screening mammography performance in Albuquerque, New Mexico, 1991 to 1993 , 1996, Cancer.

[76]  K. Kerlikowske,et al.  Incidence of and treatment for ductal carcinoma in situ of the breast. , 1996, JAMA.

[77]  D. Schultz,et al.  Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[78]  S. Schnitt,et al.  bcl‐2 expression in the spectrum of preinvasive breast lesions , 1996 .

[79]  R. Schmidt,et al.  Patient selection for breast conservation therapy with magnification mammography. , 1995, Surgery.

[80]  M. J. Silverstein,et al.  Prognostic classification of breast ductal carcinoma-in-situ , 1995, The Lancet.

[81]  L. Liberman,et al.  Displacement of carcinomatous epithelium in surgical breast specimens following stereotaxic core biopsy. , 1995, American journal of clinical pathology.

[82]  Anthony J. Guidi,et al.  Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history. , 1995, The cancer journal from Scientific American.

[83]  T. Moriya,et al.  Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma , 1994, Cancer.

[84]  P. Validire,et al.  Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity. , 1994, Seminars in diagnostic pathology.

[85]  W. Gregory,et al.  The classification of ductal carcinoma in situ and its association with biological markers. , 1994, Seminars in diagnostic pathology.

[86]  P. Bult,et al.  Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. , 1994, Seminars in diagnostic pathology.

[87]  J. Hendriks,et al.  Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. , 1994, Seminars in diagnostic pathology.

[88]  H. Oberman,et al.  Tumors of the Mammary Gland , 1994 .

[89]  Anthony J. Guidi,et al.  Microvessel density and distribution in ductal carcinoma in situ of the breast. , 1994, Journal of the National Cancer Institute.

[90]  D N Poller,et al.  Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Nottingham Breast Team. , 1993, Clinical radiology.

[91]  A. Marzoni,et al.  Ductal carcinoma in situ of the breast: results of treatment by conservative surgery and definitive irradiation. , 1994, International journal of radiation oncology, biology, physics.

[92]  D. Page,et al.  Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions , 1994, Cancer.

[93]  I. Ellis,et al.  Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein. , 1993, British Journal of Cancer.

[94]  C. Perez,et al.  Breast conservation therapy for intraductal carcinoma of the breast. , 1993, International journal of radiation oncology, biology, physics.

[95]  S. Schnitt,et al.  Estrogen receptor immunohistoohemistry in carcinoma in situ of the breast , 2010, Cancer.

[96]  T. Ravikumar,et al.  Ten-year follow-up of breast carcinoma in situ in Connecticut. , 1992, Archives of surgery.

[97]  A. Patchefsky,et al.  Subclinical ductal carcinoma in situ of the breast: Treatment by local excision and surveillance alone , 1992, Cancer.

[98]  D. Schultz,et al.  Ten‐year results of breast‐conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast , 1991, Cancer.

[99]  B. McCormick,et al.  Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy. , 1991, International journal of radiation oncology, biology, physics.

[100]  M. Silverstein,et al.  Intraductal carcinoma of the breast (208 cases): Clinical factors influencing treatment choice , 1990, Cancer.

[101]  J. Hendriks,et al.  Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situ , 1990, The Lancet.

[102]  O. Gröntoft,et al.  Follow‐up of two treatment modalities for ductal cancer in situ of the breast , 1989, The British journal of surgery.

[103]  M. Lagios,et al.  Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence , 1989, Cancer.

[104]  M P Osborne,et al.  Breast carcinoma in situ. , 1989, Archives of surgery.

[105]  David L. Page,et al.  Diagnostic Histopathology of the Breast , 1988 .

[106]  C. Key,et al.  Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study , 1987, Cancer.

[107]  J. A. Andersen,et al.  Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. , 1987, British Journal of Cancer.

[108]  Edwin Silverberg,et al.  Survival experience in the breast cancer detection demonstration project , 1987, CA: a cancer journal for clinicians.

[109]  T. Nemoto,et al.  Intraductal Carcinoma: Analysis of Presentation, Pathologic Findings, and Outcome of Disease , 1986 .

[110]  C. Alpers,et al.  The prevalence of carcinoma in situ in normal and cancer-associated breasts. , 1985, Human pathology.

[111]  W. Fletcher,et al.  Breast carcinoma in situ. A retrospective review of 112 cases with a minimum 10 year follow-up. , 1985, American journal of surgery.

[112]  R. Brown,et al.  Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women. , 1985, British Journal of Cancer.

[113]  R. Wilson,et al.  Intraductal carcinoma of the breast. , 1984, Surgery, gynecology & obstetrics.

[114]  M. Nielsen,et al.  Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women , 1984, Cancer.

[115]  G. Murphy,et al.  Noninvasive Breast Carcinoma: Results of a National Survey by the American College of Surgeons , 1980, Annals of surgery.

[116]  R. E. Snyder,et al.  Prospective study of non‐infiltrating carcinoma of the breast , 1977, Cancer.

[117]  H M Jensen,et al.  On the origin and progression of ductal carcinoma in the human breast. , 1973, Journal of the National Cancer Institute.

[118]  B. Rush,et al.  Mammary duct proliferation in the elderly. A histopathologic study , 1973, Cancer.